Prize Winning Abstracts Publications with International Presentations:

 

Haque S, Welch H, Dashwood M. Shiwen X, Abraham D, Heetun M, Farooqui N, Taylor I, Winslet M, Loizidou M,  Endothelin-1 stimulated gene induction within colonic cancer cells and fibroblasts and the effect of Endothelin receptor antagonism on key genes. ET-12 conference & published in the BPS, 2011 (Winner of Young Investigator Awards 2012)

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Winslet M, Ogunbiyi O, Dashwood M. Characterisation of Endothelin-1 binding sites in colorectal cancer and antagonistic action of the Endothelin A receptor antagonist Zibotentan (ZD4054). ET-12 conference & published in the BPS, 2011(Winner of Young Investigator Awards 2012)

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Winslet M, Ogunbiyi O, Growcott J, Dashwood M.  Characterisation of endothelin-1 binding sites in colorectal cancer and antagonistic action of the endothelin A receptor antagonist Zibotentan (ZD4054).  Brit J of Surg;98(S2):6-39 pp36, 2011 (BJS Prize winning presentation 2011-12)

 

Haque S, Welch H, Dashwood M. Shiwen X, Abraham D, Heetun M, Farooqui N, Taylor I, Winslet M, Loizidou M,  Endothelin-1 stimulated gene induction within colorectal fibroblasts and the effect of endothelin receptor antagonism on key genes.  Brit J of Surg;98(S2):6-39 pp38, 2011 (BJS Prize Runner up Presentation 2011-12)

 

 

Chapter Publications:

 

Haque S, Welch H & Loizidou M. The Endothelin Peptide. Book chapter 70 for The Handbook of Biologically Active Peptides. Ch 70, p512-518, ISBN:978-0-12-385095-9. 2nd Edition; 2013

 

Haque S. Endothelin-1 and future colorectal cancer research. Invited summary chapter on ET-1 and colorectal cancer research. BASO Yearbook 2012.

Paper Publications:

 

Haque S, Dashwood M, Shiwen X, Abraham D, Welch H. Loizidou M.  Induction of tumourogenic pathways in colorectal and tumour stroma following ET-1 exposure. Ready for submission, 2017

 

Haque S, Welch H, Dashwood M, Ramesh B, Loizidou M. Efficacy of Zibotentan in Colorectal Cancer – Response Letter. Invited letter to editors that explores novel laboratory experimental models to predict clinical outcomes. Molecular Cancer Therapeutics, Published; doi:10.1158/1535-7163.MCT-14-0002. Online First May 16, 2014

 

Haque S, Dashwood M, Heetun M, Shiwen X, Farooqui N, Welch H, Savage FJ, Ogunbiyi O, Abraham DJ, Loizidou M. Efficacy of the specific endothelin A receptor antagonist Zibotentan (ZD4054) in colorectal cancer: a preclinical study. Molecular Cancer Therapeutics. Published OnlineFirst, doi: 10,1158/1535-7163. MCT-12-0975; May 30, 2013

 

Haque S, Morton D & Welch H. Biologics against cancer-specific receptors -challenges to personalised medicine from early trial results. Invited review. Current Opinions in Pharmacology; 12 (4): 392-397, 2012

 

Knowles JP, Shiwen X, Haque S, Bhalla A, Dashwood MR, Yang S, Taylor I, Winslet MC, Abraham DJ, Loizidou M. Endothelin-1 stimulates colon cancer adjacent fibroblasts.  Int. J. Cancer: 130; p1264-p1272, 2012

 

Haque S, Winslet M, Loizidou M, Taylor I.  Endothelin receptors as an emerging target in colorectal cancers.  Therapeutic Strategies-Oncology, (Review article – currently as ebook: http://viewer.zmags.com/publication/8da7a9fc#/8da7a9fc/86), Pg86-91, 2011

 

Haque S, Heetun M, Taylor I, Shiwen X, Winslet M, Loizidou M. Efficacy of the Specific ETA Receptor Antagonist Zibotentan in Colorectal Cancer Cells and Colorectal Fibroblasts. EJSO; 35 (11): 1206, 2009

 

Bhalla A, Haque S, Taylor I, Winslet M, Loizidou M, Endothelin Receptor Antagonism and Cancer. Eur J Clin Invest; 39 (S2): 74-77, 2009

 

Heetun M, Haque S, Loizidou M. p53 at a Glance: The Story so Far.  OncologyNew Volume 4 Issue 2 May/June; 49-51, 2009

 

Haque S, Hashmi SM, Prinsley PP.  Impact of ENT Follow-up after Myringotomy and Grommet Insertion.  The West London Medical Journal; Vol 1 No 2; pp 49-57, 2009

 

Haque S, Heetun M, Ogunbiyi G. Surgical Management for Inflammatory Bowel Disease: Implications for Bowel Cancer   OncologyNews Volume 4 Issue 1: March/April; 20-22, 2009

 

Haque S, Bhalla A, Winslet M, Clinical Management of Familial Adenomatous Polyposis (FAP) and Lynch Syndrome (Hereditary Non-Polyposis Colon Cancer – HNPCC). Oncology News Volume 3 Issue 3: October/November, 2008

Haque S, Beta-blockers for elderly elective surgical patients. BMJ (Letter);331:932-4, 2005

 

 

Abstract Publications:

 

Laurent E, Uddin A, Hussain S, Toi T, Seraj S, Haque S. The Virtual Near-Peer Teaching Programme is Comparable with Traditional Classroom Teaching: A Junior Doctor Perspective. Abstract & Poster for Association for Simulated Practice in Healthcare, Nov 2020.

 

Hussain S, Toi T, Laurent E, Haque S. A Near-Peer Surgical Teaching Programme for Junior Doctors: A 16 Month Retrospective Analysis. Poster for Association of Surgeons in Training (ASiT), Oct 2020.

 

Seraj S, Hussain S, Toi T, Chaudhary O, Haque S. A near-peer surgical teaching programme for Foundation doctors, Accepted for presentations at the ASBGI Glasgow, June 2020

 

Chaudhary O, Haque S & Lovett B. Real Time CUSUM chart showing trends in NELA mortality influencing proactive changes. Accepted for presentations at the ASBGI Glasgow, June 2020

 

Laurent E, Uddin A, Niaz O, Haque S. A Virtual Teaching Program at a University Hospital: Lunch and Learn. Virtual oral presentation at MedEd20 Conference, Medics Academy.  June 2020 https://www.youtube.com/watch?v=pV4dtdqWxfM&list=PLtwHCatXqudu_BgW1VjjhRU4tYYcoczif&index=39

 

Danato-Brown D, Bryant C, Haque S & Chan C. ‘Watch and Wait’ for Rectal Cancer – A Systematic Review. Poster Presentation at ESCP, Milan. Abstract published in Colorectal Disease; 18 (Suppl. 1) p44-125, Sept 2016

 

Jamel S, Haque S, Warren S. Iatrogenic Pseudoaneurysm of the Right Hepatic Artery. National Surgical Symposium, Manchester, Nov.  2014

 

Haque S, Loizidou M, Dashwood M, Shiwen X, Abraham D, Welch H. Novel Molecular Pathways by which ETA Receptor Mediates Tumourogenic Signals in Colorectal Cancer: Support for ETA Receptor Antagonism as Adjuvant Treatment. Abstract published at ET-13 Tokyo, 8th-11th Sept. 2013

 

Haque S, Ramesh B, Welch H, Abraham D, Ogunbiyi O, Loizidou M, Dashwood M. The Localisation and Distribution of Endothelin Receptors in Normal and Cancer Colon Tissue: Confirmation by Autoradiography, Immunohistochemistry and Quantum Dot Targeting. Abstract published at ET-13 Tokyo, 8th-11th Sept. 2013

 

Haque S, Loizidou M, Shiwen X, Abraham D, Winslet M, Welch H. Identification of Endothelin-1 stimulated genes in colon cancer cells and fibroblasts and the effect of Endothelin receptor antagonism on their regulation. EJSO; 37 (11): p1012, 2011

 

Haque S, Dashwood M, Welch H, Ogunbiyi O, Loizidou M. Characterizing colorectal cancer binding sites for Endothelin-1 and antagonistic action by the Endothelin A receptor antagonist Zibotentan (ZD4054). EJSO; 37 (11): p1011, 2011

 

Goodyear G, Haque S, Bartnik A, Loizidou M, Welch H.  The E2, ERα, EFP and 14-3-3δ pathway mediates breast cancer cell proliferation.  EJSO; 37 (11): p1006, 2011

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Ogunbiyi O, Growcott J, Dashwood M.  Localisation and characterization of ET-1 binding to human colorectal cancers and evaluation of the orally active ETA receptor antagonist Zibotentan (ZD4054).  AACR Conference, Berlin, Germany, 2010. Abstract Number 161. http://www.ecco-org.eu/Conferences-and-Events/Past-events/2010-Past-Events/EORTC-NCI-AACR-2010/Abstracts-online/page.aspx/2528 
 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Ogunbiyi O, Growcott J, Dashwood M.  Localisation and characterization of ET-1 binding to human colorectal cancers and evaluation of the orally active ETA receptor antagonist Zibotentan (ZD4054).  NCRI conference 2010; 7-10 Nov; Liverpool, UK. NCRI 2010 Abstract LB89: http://www.ncri.org.uk/ncriconference/2010abstracts/abstracts/LB89.htm

 

Heetun M, Haque S, Farooqui N, Dashwood M, Winslet M, Shiwen X, Abraham D, Loizidou M. Efficacy of the specific ETA receptor antagonist zibotentan (ZD4054) in cancer cells and fibroblasts from colorectal cancer.  Brit J of Surg; 97(S6):7-38 pp16, 2010

 

Pimenta D, Haque S, Heetun M,  Dashwood M, Shiwen X, Farooqui N, Abraham D, Loizidou M. The Endothelin Axis in Drug Sensitive and Multidrug Resistant Bladder Cancer Cells. Brit J of Surg; 97(S6):7-38 pp27, 2010

 

Haque S, Heetun M, Farooqui N, Loizidou M, Dashwood M, Shiwen X, Abraham D. Efficacy of the Specific ETA Receptor antagonist Zibotentan (ZD4054) in Cancer Cells and Fibroblasts from Colorectal Cancer. Mol. Cancer Ther; 8(12 Suppl):B190, 2009

 

Joglekar SP, Haque S, Downey S. Prophylactic Antibiotics in Breast Surgery.   Brit J Surg; 95(S4): 1–33, 2008

 

Collaborative Publications:

 

The CholeS Study Research Collaborative. Population based cohort study of outcomes following cholecystectomy for benign gallbladder diseases. In press for BJS, 2016

 

The CholeS Study Research Collaborative. Population based cohort study of variation in the use of emergency cholecystectomy for benign gallbladder diseases. In press for BJS, 2016

 

CholeS Study Group. Vohra R et al. Population-based cohort study of outcomes following cholecystectomy for benign gallbladder diseases in the UK and Ireland.  Abstract HP003. ANZ J. Surg. 2016; 86 (S1) 85-91. 2016

 

CholeS Study Group. Vohra R et al. Effectiveness of antibiotic prophylaxis in non-emergency cholecystectomy.  Abstract HP014P. ANZ J. Surg. 2016; 86 (S1) 85-91. 2016

CholeS Study Group. Vohra R et al. Population-based prospective cohort study of variation in the use of emergency cholecystectomy for benign gallbladder diseases in the UK and Ireland. Abstract HP019P. ANZ J. Surg. 2016; 86 (S1) 85-91. 2016

 

The CholeS Study Research Collaborative. Vohra RS et al. Protocol for a multicentre, prospective, population-based cohort study of variation in practice of cholecystectomy and surgical outcome (The CholeS study). Paper. BMJ Open 2015;5:e006399. Doi:10.1136/bmjopen-2014-006399. 2015

 

CholeS Study Group. Causes and Effect of Variation in Practice of Cholecystectomy: a multi-centre, prospective, population-based cohort study. Abstract.  BJS 2015; 102 (S7):9-87. 2015

 

CholeS Study Group. Independent Predictors of all Cause 30-Day Readmissions Following Cholecystectomy: a Contemporary, Multi-Centre, Prospective, Population-Based Cohort Study. Abstract.  BJS 2015; 102 (S7):9-87. 2015

 

CholeS Study Group. Boel et al. The effectiveness of perioperative antibiotics to reduce surgical site infections following cholecystectomy: a systematic review and meta-analysis. Abstract ID 120. EAHPBA, 2015

 

CholeS Study Group. Prediction of conversion to an open operation during laparoscopic cholecystectomy. Abstract ID 168. EAHPBA, 2015

 

CholeS Study Group. Cholecystectomy for cholecystitis: Delayed surgery minimises conversion and 30 day complication rate. Abstract ID 177. EAHPBA, 2015

 

​

Presentations

 

Laurent E, Uddin A, Hussain S, Toi T, Seraj S, Haque S. The Virtual Near-Peer Teaching Programme is Comparable with Traditional Classroom Teaching: A Junior Doctor Perspective. Abstract & Poster for Association for Simulated Practice in Healthcare, Nov 2020.

 

Hussain S, Toi T, Laurent E, Haque S. A Near-Peer Surgical Teaching Programme for Junior Doctors: A 16 Month Retrospective Analysis. Poster for Association of Surgeons in Training (ASiT), Oct 2020. 

 

Seraj S, Hussain S, Toi T, Chaudhary O, Haque S. A near-peer surgical teaching programme for Foundation doctors, Accepted for presentations at the ASBGI Glasgow, June 2020

 

Chaudhary O, Haque S & Lovett B. Real Time CUSUM chart showing trends in NELA mortality influencing proactive changes. Accepted for presentations at the ASBGI Glasgow, June 2020

 

Laurent E, Uddin A, Niaz O, Haque S. A Virtual Teaching Program at a University Hospital: Lunch and Learn. Virtual oral presentation at MedEd20 Conference, Medics Academy.  June 2020 https://www.youtube.com/watch?v=pV4dtdqWxfM&list=PLtwHCatXqudu_BgW1VjjhRU4tYYcoczif&index=39

 

Haque S. Overview of Endothelin and Gene regulation in Cancer Fibroblasts and why this is of interest in Inflammatory Bowel Disease. Oral presentation at Saint Antoine Hospital, Paris, France. March 2018

 

Jamel S, Haque S, Warren S. Iatrogenic Pseudoaneurysm of the Right Hepatic Artery. National Surgical Symposium, Manchester, Nov.  2014

 

Haque S, Loizidou M, Dashwood M, Shiwen X, Abraham D, Welch H. Novel Molecular Pathways by which ETA Receptor Mediates Tumourogenic Signals in Colorectal Cancer: Support for ETA Receptor Antagonism as Adjuvant Treatment. Poster at ET-13 Tokyo, 8th-11th Sept. 2013

 

Haque S, Ramesh B, Welch H, Abraham D, Ogunbiyi O, Loizidou M, Dashwood M. The Localisation and Distribution of Endothelin Receptors in Normal and Cancer Colon Tissue: Confirmation by Autoradiography, Immunohistochemistry and Quantum Dot Targeting. Poster at ET-13 Tokyo, 8th-11th Sept. 2013

 

Haque S, Loizidou M, Shiwen X, Abraham D, Winslet M, Welch H. Identification of Endothelin-1 stimulated genes in colon cancer cells and fibroblasts and the effect of Endothelin receptor antagonism on their regulation. BJS Prize session oral presentation, BASO 2011.

 

Haque S, Dashwood M, Welch H, Ogunbiyi O, Loizidou M. Characterizing colorectal cancer binding sites for Endothelin-1 and antagonistic action by the Endothelin A receptor antagonist Zibotentan (ZD4054). BJS Prize session oral presentation, BASO 2011.

 

Goodyear G, Haque S, Bartnik A, Loizidou M, Welch H.  The E2, ERα, EFP and 14-3-3δ pathway mediates breast cancer cell proliferation.  Poster Presentation, BASO 2011.

 

Haque S, Welch H, Dashwood M. Shiwen X, Abraham D, Heetun M, Farooqui N, Taylor I, Winslet M, Loizidou M,  Endothelin-1 stimulated gene induction within colonic cancer cells and fibroblasts and the effect of Endothelin receptor antagonism on key genes. ). Accepted for ET-12 international conference oral presentation, Cambridge 2011

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Winslet M, Ogunbiyi O, Dashwood M. Characterisation of Endothelin-1 binding sites in colorectal cancer and antagonistic action of the Endothelin A receptor antagonist Zibotentan (ZD4054). Accepted for ET-12 international conference poster presentation, Cambridge 2011

 

Haque S, Welch H, Dashwood M. Shiwen X, Abraham D, Heetun M, Farooqui N, Taylor I, Winslet M, Loizidou M,  Endothelin-1 stimulated gene induction within colorectal fibroblasts and the effect of endothelin receptor antagonism on key genes.  Oral Presentation, SARS 2011

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Winslet M, Ogunbiyi O, Growcott J, Dashwood M.  Characterisation of endothelin-1 binding sites in colorectal cancer and antagonistic action of the endothelin A receptor antagonist Zibotentan (ZD4054).  Oral Presentation, SARS 2011.

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Ogunbiyi O, Growcott J, Dashwood M.  Localisation and characterization of ET-1 binding to human colorectal cancers and evaluation of the orally active ETA receptor antagonist Zibotentan (ZD4054).  Poster presentation for NCRI, 2010.

 

Haque S, Loizidou M, Shiwen X, Abraham D, Farooqui N, Welch H, Ogunbiyi O, Growcott J, Dashwood M.  Localisation and characterization of ET-1 binding to human colorectal cancers and evaluation of the orally active ETA receptor antagonist Zibotentan (ZD4054).  Poster presentation for AACR, 2010.

 

Heetun M, Haque S, Farooqui N, Dashwood M, Winslet M, Shiwen X, Abraham D, Loizidou M

Efficacy of the specific ETA receptor antagonist zibotentan (ZD4054) in cancer cells and fibroblasts from colorectal cancer.  Oral Presentation, SARS 2010

 

Pimenta D, Haque S, Heetun M,  Dashwood M, Shiwen X, Farooqui N, Abraham D, Loizidou M. The Endothelin Axis in Drug Sensitive and Multidrug Resistant Bladder Cancer Cells.

Oral Presentation, SARS 2010 

 

Haque S, Heetun M, Farooqui N, Loizidou M, Dashwood M, Shiwen X, Abraham D. Efficacy of the Specific ETA Receptor antagonist Zibotentan (ZD4054) in Cancer Cells and Fibroblasts from Colorectal Cancer. Poster Presentation at AACR International Conference, Boston. 2009

 

Heetun M, Haque S, Farooqui N, Dashwood M, Winslet M, Shiwen X, Abraham D, Loizidou M.  Efficacy of the specific ETA receptor antagonist zibotentan (ZD4054) in cancer cells and fibroblasts from colorectal cancer.  Oral presentation at ET-11 Conference, Canada. 2009

 

Pimenta D, Haque S, Heetun M,  Dashwood M, Shiwen X, Farooqui N, Abraham D, Loizidou M.  The Endothelin Axis in Drug Sensitive and Multidrug Resistant Bladder Cancer Cells.   Poster presentation at ET-11 Conference, Canada. 2009

 

Haque S, Heetun M, Taylor I, Shiwen X, Winslet M, Loizidou M.  Efficacy of the Specific ETA Receptor Antagonist Zibotentan in Colorectal Cancer Cells and Colorectal Fibroblasts. Oral presentation, BASO, 2009 

 

Haque S, Hashmi S, Prinsley P. Clinical and Economic Impact of Post-Myringotomy and Grommet Follow-up: What is the Way Forward? Regional Presentation. Written as paper published in: The West London Medical Journal; Vol 1 No 2; pp 49-57, 2009.

 

Joglekar SP, Haque S, Downey S. Prophylactic Antibiotics in Breast Surgery.  Poster presentation at SARS. 2008

 

Haque S, Jones. Audit into complications following total hip replacements. Presented at the local MDT and combined surgical meetings.